Asian Open: Biotech Leads the Way in an Otherwise Quiet Session
Matt Simpson June 8, 2021 7:52 AM
US regulators approved Alzheimer drug Aduhelm, sending Biogen’s stock soaring around 60% and leading to a mid-session trading halt.
- Australia's ASX 200 futures are up 5 points (0.07%), the cash market is currently estimated to open at 7,286.90
- Japan's Nikkei 225 futures are up 130 points (0.45%), the cash market is currently estimated to open at 29,149.24
- Hong Kong's Hang Seng futures are up 15 points (0.05%), the cash market is currently estimated to open at 28,802.28
UK and Europe:
- UK's FTSE 100 index rose 8.18 points (0.12%) to close at 7,077.22
- Europe's Euro STOXX 50 index rose 8.27 points (0.2%) to close at 4,097.65
- Germany's DAX index fell -15.75 points (-0.1%) to close at 15,677.15
- France's CAC 40 index rose 27.9 points (0.43%) to close at 6,543.56
Monday US Close:
- The Dow Jones Industrial fell -126.15 points (-0.36%) to close at 34,630.24
- The S&P 500 index fell -3.37 points (-0.08%) to close at 4,226.52
- The Nasdaq 100 index rose 32.117 points (0.23%) to close at 13,802.89
Learn how to trade indices
The Nasdaq biotech index (NBI) rallied 3.62% thanks to the approval of Biogen’s (BIIB) Alzheimer drug, and providing levels of volatility usually associate with meme stocks. Its share price rallied over 63% at its high yesterday to a new record, before tailing off to close ‘just’ 38.3% up for the session and beneath its previous record high.
Elsewhere, with earnings out of the way and several key data points pending this week, the lack of a catalyst has taken its toll on volatility. The S&P 500 closed effectively flat at -0.08%, with six of its 11 sectors closing lower (led by materials, financial and energy stocks). The Dow Jones closed -0.36% lower whilst the Nasdaq 100 settled for a minor 0.23% gain. The Russell 2000 rose 1.43% led by growth stocks (1.79%), whilst value stocks rose 1.12%.
The ASX 200 broke a three-day rally after failing to hold onto earlier gains or its break above 7300. Its RSI (2) had risen to 95.5 on Friday warning of a possible down day, and whilst we remain bullish overall we do see the potential for a minor retracement. Heading into today’s session, key resistance sits at 7289.50 – 7291.20 and 7296.30 – 72980.0, with key support sitting at 7280 and 7270.0.
ASX 200 Market Internals:
ASX 200: 7281.9 (-0.19%), 07 June 2021
- Information Technology (2.8%) was the strongest sector and Consumer Discretionary (-0.89%) was the weakest
- 9 out of the 11 sectors closed higher
- 98 (49.00%) stocks advanced, 89 (44.50%) stocks declined
- 13 hit a new 52-week high, 0 hit a new 52-week low
- 73.5% of stocks closed above their 200-day average
- 68.5% of stocks closed above their 50-day average
- 77.5% of stocks closed above their 20-day average
- + 39.03% - Altium Ltd (ALU.AX)
- + 6.18% - Nuix Ltd (NXL.AX)
- + 6.13% - Appen Ltd (APX.AX)
- -6.47% - Skycity Entertainment Group Ltd (SKC.AX)
- -5.14% - Corporate Travel Management Ltd (CTD.AX)
- -4.91% - Webjet Ltd (WEB.AX)
The Australian and New Zealand dollars were the strongest majors overnight, with all but the Canadian dollar rising against the US dollar. CAD was the weakest major of the session thanks to lower oil prices and the likelihood that traders squared up positions ahead of Wednesday’s BOC meeting (Bank of Canada) meeting. Month-to-date, AUD and JPY are the strongest majors whilst NZD and EUR are the weakest.
The US dollar index (DXY) fell to a two-day low and closed back below 90.00 after finding resistance at its 50-day eMA on Friday.
AUD/CHF couldn’t quite break above 0.6980 resistance and instead closed the day with a bearish pinbar just above the halfway point between 0.6917 – 0.6982. Until a break of this range is seen, range trading strategies are preferred.
CHF/JPY remains in a strong uptrend on its daily chart, although prices have been gently consolidating since reaching its 5-year high in May. Prices remain above the 20-day eMA and currently above 121.52 support. Given the RSI (2) appears set to dip below 10, level which can be associated with overbought, we are on guard for a corrective low to form and its trend to resume. Whilst this may be a little premature, we are seeking evidence that a swing low has formed, ideally above or around the 38.2% Fibonacci level at 121.30.
Learn how to trade forex
WTI prices remained below $70 after confirming it as resistance during yesterday’s Asian trade. A small Doji has formed below this key resistance level suggesting prices may dip lower on from a technical perspective, with next support level to monitor around 67.98 – 68.00.
Lumber futures were down another -4.5% ad sits at a 1-day low. Having fallen over 30% since its May high, lumber is now in a technical bear market. Should copper continue to fall it adds credit to the Feds argument that inflation may indeed be transitory.
As for copper, prices held above 4.435 for a second consecutive day although upside potential remains capped whilst prices trade below 4.5815 resistance. But with net-long exposure now its lowest in nearly a year, with large speculators continuing to reduce bullish exposure and increase bearish exposure, we are wondering how much longer copper prices can remain elevated. As either prices are too high, or bullish exposure is too low.
Spot gold rose to a two-day high yet remains below 1900. Given the rise of volatility (and most notably, Thursday’s large bearish candle) we suspect we could be at a ‘distribution phase’ of its trend, so we’re on guard for further losses whilst prices remain beneath the 1916.53 high.
Up Next (Times in AEST)
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.